Aratana adds pet therapies in $38M deal to acquire Vet

John Carroll

Therapeutics has struck a to buy San Diego-based Vet Therapeutics, adding new pet to its pipeline for $ 30 million in cash, a chunk of stock, a promissory note for $ 3 million and up to $ 5 million in milestone payments.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS